PATENT CLAIM ANALYSIS

Application Number: 15748804
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "289000"]

Abstract:
This invention relates to methods of treating agitation comprising administering a morphinan compound or a pharmaceutically acceptable salt thereof. This invention also provides the use in methods of treating agitation and related disorders with such a morphinan compound in combination with quinidine, or pharmaceutically acceptable salt of either or both thereof.

Claim (Index 4):
The method of  claim 3 , wherein the compound of Formula I is a compound selected from the table: Compound No. R 1 R 2 100 \u2014O\u2014CD 2 CD 3 CD 3 101 \u2014O\u2014CD 2 CH 3 CD 3 102 \u2014O\u2014CH 2 CH 3 CD 3 103 \u2014O\u2014CH 2 CD 3 CD 3 104 \u2014O\u2014CD 2 CD 3 CH 3 105 \u2014O\u2014CD 2 CH 3 CH 3 106 \u2014O\u2014CH 2 CD 3 CH 3 or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 86.0
- Lexical Diversity: 1.58824
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15148568', '14726758', '14546173', '14208968', '13119905']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.813025293726265
- 35 USC 102 Novelty (BERT): 0.5254799901058447
- Combined Prediction Score: 0.784270763364223
- Mean Citation Score: 332.409086
- Max Citation Score: 341.80304
- Similarity Product: 270.9880133956051

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test